GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Accounts Payable

Kadimastem (XTAE:KDST) Accounts Payable : ₪2.07 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kadimastem Accounts Payable?

Kadimastem's Accounts Payable for the quarter that ended in Dec. 2024 was ₪2.07 Mil.

Kadimastem's quarterly Accounts Payable declined from Dec. 2023 (₪1.93 Mil) to Jun. 2024 (₪1.21 Mil) but then increased from Jun. 2024 (₪1.21 Mil) to Dec. 2024 (₪2.07 Mil).

Kadimastem's annual Accounts Payable declined from Dec. 2022 (₪3.69 Mil) to Dec. 2023 (₪1.93 Mil) but then increased from Dec. 2023 (₪1.93 Mil) to Dec. 2024 (₪2.07 Mil).


Kadimastem Accounts Payable Historical Data

The historical data trend for Kadimastem's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadimastem Accounts Payable Chart

Kadimastem Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.83 3.18 3.69 1.93 2.07

Kadimastem Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 1.95 1.93 1.21 2.07

Kadimastem Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Kadimastem Accounts Payable Related Terms

Thank you for viewing the detailed overview of Kadimastem's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Kadimastem Business Description

Traded in Other Exchanges
N/A
Address
Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem Headlines

No Headlines